Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
ABCD PBi
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
Autor:
Jordan, B.
;
Margulies, A.
;
Cardoso
,
F
.
;
Cavaletti, G.
;
Haugnes, H.S.
;
Jahn, P.
;
Le Rhun, E.
;
Preusser, M.
;
Scotté,
F
.
;
Taphoorn, M.J.B.
;
Jordan, K.
Assuntos:
Antineoplastic Agents - adverse effects
;
central neuropathy
;
CIPN
;
Clinical Practice Guidelines
;
diagnosis
;
Follow-Up Studies
;
Humans
;
Neurotoxicity Syndromes - diagnosis
;
Neurotoxicity Syndromes - epidemiology
;
Neurotoxicity Syndromes - etiology
;
Peripheral Nervous System Diseases
;
peripheral neurotoxicity
;
treatment
É parte de:
Annals of oncology, 2020-10, Vol.31 (10), p.1306-1319
Descrição:
•This ESMO–EONS–EANO Clinical Practice Guideline provides key recommendations on the management of therapy-induced peripheral and central neurotoxicity.•Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe.•Recommendations are based on available scientific data and the authors' collective expert opinion.•An algorithm on the practical approach to assessing chemotherapy-induced peripheral neurotoxicity is provided.
Editor:
England: Elsevier Ltd
Idioma:
Inglês